Natural Alternatives International, Inc. (NAII) can hold. Click on Rating Page for detail.
The price of Natural Alternatives International, Inc. (NAII) is 6.5 and it was updated on 2024-04-23 01:21:41.
Currently Natural Alternatives International, Inc. (NAII) is in undervalued.
News |
---|
Natural Alternatives International, Inc. Announces 2021 Q4 and YTD Results
|
Natural Alternatives International, Inc. Announces Acquisition of Manufacturing and Warehouse Facility
|
Natural Alternatives International, Inc. Announces New and Expanded Credit Facility with Wells Fargo Bank
|
Natural Alternatives International, Inc. Announces a $3 Million Increase in its Stock Repurchase Plan
|
Natural Alternatives International, Inc. Announces 2021 Q1 Results
|
StockPrice Release |
---|
News |
---|
Jeff Davanon Joins Carnosyn® Brands
|
Natural Alternatives International, Inc. (NASDAQ:NAII) Short Interest Down 7.1% in June
|
Natural Alternatives International, Inc. (NASDAQ:NAII) Sees Significant Drop in Short Interest
|
Natuzzi S.p.A.: Unaudited Consolidated Results for the Fourth Quarter and Full Year 2019 | MarketScreener
|
Natural Alternatives Q3 EPS $(0.610) Down From $0.270 YoY, Sales $25.482M Down From $35.455M YoY
|
Natural Alternatives International, Inc. Announces 2020 Q3 and YTD Results
|
Analysis on New Product Launches in Covid-19 Related Markets-Global Animal Wound Care Market 2020-2024 | Evolving Opportunities with 3M Co. and B. Braun Melsungen AG | Technavio
|
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Natural Alternatives International, Inc. - NAII
|
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Natural Alternatives International, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
|
INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Natural Alternatives International, Inc. for Potential Breach of Fiduciary Duty Claims
|
INVESTOR ALERT: Fields Kupka & Shukurov LLP Is Investigating Natural Alternatives ...
|
Our Take On Natural Alternatives International, Inc.'s (NASDAQ:NAII) CEO Salary
|
Stocks That Hit 52-Week Lows On Friday
|
Natural Alternatives International, Inc. Earlier Announces Increase In Buyback By $1M To A Total Of $10M
|
Natural Alternatives International, Inc. Announces Increase in its Stock Repurchase Plan
|
CarnoSyn® Brands Enters Third Year of Strategic Partnership with TEST Football Academy
|
Stocks That Hit 52-Week Lows On Friday
|
Stocks That Hit 52-Week Lows On Wednesday
|
Natural Alternatives Q2 EPS $0.07 Down From $0.31 YoY, Sales $29.103M Down From $36.043M YoY
|
Natural Alternatives International, Inc. Announces 2020 Q2 and YTD Results
|
CarnoSyn® Brands Presenting Latest Health And Wellness Solutions During IHS Conference
|
Should You Worry About Natural Alternatives International, Inc.’s (NASDAQ:NAII) ROCE?
|
Natural Alternatives International Adds $2M To Buyback
|
Natural Alternatives International increases stock repurchase program by $2M NAII
|
Stocks That Hit 52-Week Lows On Friday
|
Stocks That Hit 52-Week Lows On Friday
|
Natural Alternatives Q1 EPS $0.01 Down From $0.37 YoY, Sales $29.2M Down From $36.532M YoY
|
Natural Alternatives International, Inc. Announces 2020 Q1 Results
|
Natural Alternatives reports Q1 results
|
CarnoSyn® Brands Showcasing Groundbreaking Health And Wellness Solutions At AMMG Conference
|
Do You Like Natural Alternatives International, Inc. (NASDAQ:NAII) At This P/E Ratio?
|
CarnoSyn® Brands Showcasing Latest Innovations At SupplySide West
|
Stocks That Hit 52-Week Lows On Wednesday
|
Natural Alternatives International, Inc. Announces Fiscal Year 2019 and Q4 Results
|
Natural Alternatives Q4 EPS $(0.03) Down From $0.38 YoY, Sales $30.26M Down From $39.213M YoY
|
The Natural Products Association Honors CarnoSyn® Beta-Alanine with the 2019 Novel Ingredient and Science Award
|
Can You Imagine How Natural Alternatives International's (NASDAQ:NAII) Shareholders Feel About The 81% Share Price Increase?
|
Should Natural Alternatives International, Inc.’s (NASDAQ:NAII) Weak Investment Returns Worry You?
|
What Kind Of Shareholder Appears On The Natural Alternatives International, Inc.'s (NASDAQ:NAII) Shareholder Register?
|
Natural Alternatives Q3 EPS $0.27 Down From $0.3 YoY, Sales $35.455M Up From $31.815M YoY
|
Natural Alternatives Announces Extension to Its Multi-Year Exclusive Manufacturing Agreement with The Juice Plus+ Company
|
Natural Alternatives International, Inc. Prevails In Much-Anticipated Federal Circuit Appeal On CarnoSyn Beta-Alanine Patents; Court Holds That CarnoSyn Patents Are 'Patent Eligible'
|
Natural Alternatives' CarnoSyn Beta-Alanine Receives New Dietary Ingredient Status From The FDA
|
Natural Alternatives Q2 EPS $0.31 Up From $0.29 YoY, Sales $36.04M Up From $33.335M YoY
|
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 14, 2018
|
Natural Alternatives Q1 EPS $0.37 Up From $0.21 YoY, Sales $36.53M Up From $28.074M YoY
|
Natural Alternatives Q4 EPS $0.41 Up From $0.23 YoY, Sales $39.2M Up From $32.185M YoY
|
Natural Alternatives Q3 EPS $0.30 Up From $0.11 YoY, Sales $25.1M Down From $25.135M YoY
|
Natural Alternatives Reports Q2 Adj. EPS $0.29, Sales $33.335M vs $30.559M Est.
|
Natural Alternatives Int'l. Late Wed. Night Reported Allowance Of New US Sustained Release Beta-Alanine Patent App
|
Natural Alternatives Reports Q1 EPS $0.21 vs $0.37 In Same Qtr. Last Year, Sales $28.074M vs $34.067M
|
Natural Alternatives Reports Q4 EPS $0.23 vs $0.52 In Same Qtr. Last Year, Sales $32.185M vs $35.699M YoY
|
Natural Alternatives Reports Will Contest Prelim. Beta-Alanine Patent Ruling
|
Natural Alternatives Reports Q3 EPS $0.11 vs $0.46 in Same Qtr. Last Year, Sales $25.135M
|
Natural Alternatives International, Inc. Reports SR CarnoSyn Receives GRAS Affirmation
|
A Micro Stock With Significant Upside Potential
|
18 Biggest Mid-Day Losers For Wednesday
|
Natural Alternatives International Reports Q2 EPS $0.37 vs. Prior Year Quarter $0.28, Rev. $30.559M vs. Prior Year Quarter $26.91M
|
6 Stocks That Plummeted The Past Three Days On Increasing Volume
|
Natural Alternatives Reports Q1 EPS $0.37 vs. Prior Year Quarter $0.18, Rev. $34.06M vs. Prior Year Quarter $32.58M
|
Worst Performing Industries For October 31, 2016
|
Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Expectations
|
Natural Alternatives Reports Q4 EPS $0.52, Sales $35.7M
|
Top Performing Industries For September 6, 2016
|
Benzinga's Volume Movers
|
Natural Alternatives Int'l Reports Q3 EPS $0.46 Vs Prior $0.12, Sales $30.006M Vs Prior $19.613M
|
Seeking Alpha Pro Article: Large Downside Expected Near-Term For Natural Alternatives International, Inc.
|
Natural Alternatives International, Inc. Settles Patent Infringement Claims Against Woodbolt, Grants Woodbolt License To the Beta-Alanine Patents; Other Terms Confidential
|
Natural Alternatives Reports Q2 EPS $0.28, Sales $26.9M
|
Tiny Titans
|
Stocks Hitting 52-Week Highs
|
Stocks Hitting 52-Week Highs
|
Natural Alternatives int'l Reports Q1 EPS $0.18, Sales $21.6M, no estimates
|
Natural Alternatives International Names Michael Fortin CFO
|
Natural Alternatives International Reports FY15 EPS $0.49, Rev. $79.5M; Estimates Not Available
|
Top Performing Industries For September 4, 2015
|
Top Performing Industries For May 18, 2015
|
Natural Alternatives Int'l Reports Q3 EPS $0.12, Sales $19.6M, no estimates
|
Natural Alternatives Int'l Reports Q4 EPS $0.16, Sales $18.6M, No Estimates Available
|
Worst Performing Industries For November 20, 2014
|
Natural Alternatives International, Inc. Reports Q3 EPS of $0.07; Revenue of $18.70M
|
Morning Market Movers
|
Top Performing Industries For September 22, 2014
|
Natural Alternatives International, Inc. Reports Q2 EPS of $0.03; Revenue of $16.50M
|
Natural Alternatives Internati Reports Q4 EPS $0.11; Revenues $20.9M
|
Health Care Sector Wrap
|
Natural Alternatives International Announces Issuance of New U.S. Patent Covering CarnoSyn Beta-alanine
|
Natural Alternatives International Settles Patent Infringement Dispute With BPI Sports and Image Sports Over its Patented CarnoSyn Beta-Alanine
|
Natural Alternatives International Files Patent Infringement Claim Against DNP International Co
|
Natural Alternatives International Announces Texas Suit Against Woodbolt Distribution
|
Natural Alternatives International Announces Issuance of New U.S. Beta-Alanine Patent Protecting CarnoSyn Products
|
Natural Alternatives International Inc. (NAII) CEO Mark A Ledoux buys 1,316 Shares
|
Natural Alternatives International, Inc. Announces Resolution of Patent Litigation Case and Renewal of Beta-Alanine Licensing Agreement With Compound Solutions, Inc.
|
Natural Alternatives International Announces Stock Repurchase Plan of up to $2M
|
Morning Market Losers
|
Natural Alternatives International Reports Q2 EPS of $0.14
|
Natural Alternatives: Lagres % Drop Stock Of NASDAQ (NAII)
|
Natural Alternatives International, Inc. Announces Supply Agreement With Nestle
|
Natural Alternatives International, Inc. (NAII) Announces Financial Results
|